NPI: 1295118883 · CAMBRIDGE, OH 43725 · Federally Qualified Health Center (FQHC) · NPI assigned 07/01/2015
Authorized official ATKINSON, DANIEL controls 20+ related entities in our dataset. Read more
| Authorized Official | ATKINSON, DANIEL (CEO) |
| NPI Enumeration Date | 07/01/2015 |
Other providers sharing the same authorized official: ATKINSON, DANIEL
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 68,553 | $789K |
| 2019 | 78,026 | $839K |
| 2020 | 97,702 | $907K |
| 2021 | 191,968 | $2.49M |
| 2022 | 260,359 | $3.87M |
| 2023 | 304,119 | $4.58M |
| 2024 | 155,182 | $2.65M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| T1015 | Clinic visit/encounter, all-inclusive | 128,956 | 101,713 | $9.39M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 142,660 | 75,240 | $2.99M |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 15,453 | 9,136 | $461K |
| 90832 | Psychotherapy, 30 minutes with patient | 16,953 | 7,584 | $348K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 17,956 | 8,841 | $272K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 7,468 | 4,410 | $248K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 15,778 | 8,069 | $204K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 7,400 | 3,998 | $201K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 4,608 | 2,590 | $143K |
| G0467 | Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 5,736 | 4,629 | $126K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 1,429 | 1,277 | $121K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 3,515 | 1,933 | $108K |
| 90834 | Psychotherapy, 45 minutes with patient | 3,868 | 1,809 | $99K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 5,967 | 3,191 | $95K |
| 90837 | Psychotherapy, 53 minutes with patient | 1,842 | 810 | $75K |
| D1110 | Prophylaxis - adult | 4,677 | 3,249 | $72K |
| 90670 | 2,351 | 1,575 | $68K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1,805 | 1,108 | $65K |
| D0150 | Comprehensive oral evaluation - new or established patient | 5,731 | 3,719 | $57K |
| D0330 | Panoramic radiographic image | 3,148 | 2,299 | $54K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 8,086 | 4,347 | $51K |
| D1120 | Prophylaxis - child | 4,630 | 3,162 | $49K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 13,270 | 4,706 | $49K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2,052 | 1,108 | $44K |
| D1206 | Topical application of fluoride varnish | 5,755 | 3,874 | $40K |
| D0120 | Periodic oral evaluation - established patient | 4,924 | 3,135 | $40K |
| 36415 | Collection of venous blood by venipuncture | 20,206 | 12,261 | $33K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 5,186 | 1,681 | $33K |
| 92551 | 8,762 | 5,152 | $31K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 421 | 362 | $30K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 839 | 473 | $29K |
| Q3014 | Telehealth originating site facility fee | 3,772 | 2,086 | $28K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 553 | 416 | $27K |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | 1,421 | 763 | $24K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2,079 | 1,652 | $23K |
| H1000 | Prenatal care, at-risk assessment | 222 | 191 | $22K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 529 | 345 | $21K |
| D7140 | Extraction, erupted tooth or exposed root | 1,259 | 560 | $20K |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | 1,248 | 653 | $20K |
| 83036 | Hemoglobin; glycosylated (A1C) | 4,773 | 2,853 | $19K |
| D0274 | Bitewings - four radiographic images | 2,885 | 2,190 | $18K |
| D0140 | Limited oral evaluation - problem focused | 2,359 | 1,543 | $18K |
| 99174 | 3,260 | 2,024 | $17K | |
| 99177 | 3,465 | 2,107 | $15K | |
| 81025 | 3,316 | 2,130 | $14K | |
| 90698 | 1,114 | 738 | $12K | |
| 90633 | 1,327 | 942 | $11K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 607 | 329 | $10K |
| 90651 | 158 | 130 | $10K | |
| D0272 | Bitewings - two radiographic images | 2,080 | 1,470 | $10K |
| 99401 | 533 | 376 | $9K | |
| 90686 | 2,419 | 1,579 | $9K | |
| 0012A | 225 | 223 | $9K | |
| 76830 | Ultrasound, transvaginal | 138 | 125 | $9K |
| 0011A | 188 | 188 | $8K | |
| 90671 | 756 | 387 | $7K | |
| D2393 | Resin-based composite - three surfaces, posterior, primary or permanent | 271 | 155 | $7K |
| 80305 | 1,284 | 606 | $7K | |
| 99188 | 745 | 402 | $7K | |
| 90734 | 164 | 133 | $6K | |
| 96161 | 4,654 | 2,531 | $6K | |
| G2025 | Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | 391 | 287 | $5K |
| D0220 | Intraoral - periapical first radiographic image | 2,378 | 1,706 | $5K |
| 85018 | 4,040 | 2,512 | $5K | |
| 82962 | 3,836 | 2,312 | $5K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 513 | 304 | $5K |
| 96127 | 1,964 | 1,221 | $4K | |
| 99381 | 125 | 56 | $4K | |
| 90710 | 91 | 75 | $4K | |
| 90697 | 2,251 | 1,282 | $4K | |
| 81003 | 3,344 | 2,014 | $3K | |
| D2330 | 144 | 57 | $3K | |
| D0210 | Intraoral - complete series of radiographic images | 178 | 139 | $3K |
| D1351 | Sealant - per tooth | 174 | 29 | $3K |
| D0230 | Intraoral - periapical each additional radiographic image | 689 | 448 | $2K |
| 0064A | 51 | 51 | $2K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 57 | 38 | $2K |
| 96160 | 1,269 | 1,228 | $2K | |
| 0001A | 30 | 30 | $2K | |
| 59430 | 41 | 24 | $2K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 29 | 26 | $2K |
| 0072A | 24 | 23 | $1K | |
| 0071A | 24 | 23 | $1K | |
| 90756 | 81 | 66 | $1K | |
| 0002A | 28 | 28 | $1K | |
| 90716 | 270 | 225 | $1K | |
| 99173 | 790 | 485 | $920.85 | |
| 90744 | 591 | 387 | $876.50 | |
| 36416 | 402 | 248 | $745.01 | |
| 90707 | 269 | 222 | $697.58 | |
| 90677 | 861 | 621 | $610.98 | |
| 90474 | 170 | 121 | $599.28 | |
| 87428 | 20 | 13 | $472.50 | |
| 90681 | 1,279 | 743 | $438.00 | |
| 90672 | 42 | 33 | $417.94 | |
| 90715 | 46 | 40 | $413.52 | |
| 87807 | 71 | 31 | $380.91 | |
| 80061 | Lipid panel | 54 | 38 | $375.28 |
| 90700 | 183 | 142 | $317.75 | |
| 90674 | 21 | 12 | $292.20 | |
| 90696 | 119 | 90 | $209.18 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 217 | 116 | $202.42 |
| D0180 | 19 | 13 | $166.02 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 14 | 12 | $154.16 |
| 90685 | 56 | 40 | $136.00 | |
| 82044 | 54 | 39 | $121.53 | |
| D0270 | 88 | 60 | $115.50 | |
| 90461 | 2,499 | 1,928 | $80.00 | |
| 90713 | 27 | 24 | $10.00 | |
| 91301 | 355 | 344 | $3.54 | |
| 91300 | 17 | 14 | $0.17 | |
| G8484 | Influenza immunization was not administered, reason not given | 65,031 | 33,190 | $0.00 |
| 4004F | 53,596 | 28,673 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 69,748 | 36,221 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 108,598 | 55,538 | $0.00 |
| G9899 | Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results documented and reviewed | 2,809 | 1,452 | $0.00 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 8,433 | 4,797 | $0.00 |
| 3078F | 2,128 | 1,149 | $0.00 | |
| G8753 | Most recent systolic blood pressure >= 140 mmhg | 267 | 218 | $0.00 |
| 2022F | 1,442 | 916 | $0.00 | |
| G9900 | Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results were not documented and reviewed, reason not otherwise specified | 565 | 295 | $0.00 |
| G8482 | Influenza immunization administered or previously received | 4,535 | 2,353 | $0.00 |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 2,050 | 1,045 | $0.00 |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 315 | 250 | $0.00 |
| G8598 | Aspirin or another antiplatelet therapy used | 410 | 265 | $0.00 |
| 3046F | 516 | 303 | $0.00 | |
| 3045F | 49 | 48 | $0.00 | |
| G8938 | Bmi is documented as being outside of normal parameters, follow-up plan is not documented, documentation the patient is not eligible | 1,028 | 356 | $0.00 |
| 3077F | 82 | 39 | $0.00 | |
| G9906 | Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) | 46,533 | 24,226 | $0.00 |
| 1036F | 58,691 | 30,290 | $0.00 | |
| G9717 | Documentation stating the patient has had a diagnosis of bipolar disorder | 9,880 | 5,341 | $0.00 |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 9,842 | 5,583 | $0.00 |
| 90656 | 194 | 189 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 16,008 | 8,445 | $0.00 |
| 3017F | 20,158 | 10,845 | $0.00 | |
| G9902 | Patient screened for tobacco use and identified as a tobacco user | 48,210 | 25,096 | $0.00 |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 55,159 | 27,967 | $0.00 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 11,357 | 6,626 | $0.00 |
| 3074F | 2,254 | 1,228 | $0.00 | |
| 3079F | 1,579 | 828 | $0.00 | |
| G8432 | Depression screening not documented, reason not given | 1,218 | 862 | $0.00 |
| 3075F | 501 | 266 | $0.00 | |
| G8756 | No documentation of blood pressure measurement, reason not given | 620 | 324 | $0.00 |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 545 | 331 | $0.00 |
| G8428 | Current list of medications not documented as obtained, updated, or reviewed by the eligible clinician, reason not given | 245 | 145 | $0.00 |
| G8755 | Most recent diastolic blood pressure >= 90 mmhg | 61 | 60 | $0.00 |
| 3044F | 380 | 262 | $0.00 | |
| 3014F | 1,096 | 727 | $0.00 | |
| 99024 | 12 | 12 | $0.00 | |
| 90619 | 36 | 29 | $0.00 | |
| G8433 | Screening for depression not completed, documented patient or medical reason | 94 | 81 | $0.00 |
| G9908 | Patient identified as tobacco user did not receive tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) | 112 | 37 | $0.00 |